SI0917571T1 - Agouti-related gene - Google Patents

Agouti-related gene

Info

Publication number
SI0917571T1
SI0917571T1 SI9730696T SI9730696T SI0917571T1 SI 0917571 T1 SI0917571 T1 SI 0917571T1 SI 9730696 T SI9730696 T SI 9730696T SI 9730696 T SI9730696 T SI 9730696T SI 0917571 T1 SI0917571 T1 SI 0917571T1
Authority
SI
Slovenia
Prior art keywords
art
agouti
related gene
disclosed
adrenal
Prior art date
Application number
SI9730696T
Other languages
English (en)
Slovenian (sl)
Inventor
Kevin Lee Stark
Roland Luethy
Original Assignee
Amgen Inc.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc., filed Critical Amgen Inc.,
Publication of SI0917571T1 publication Critical patent/SI0917571T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
SI9730696T 1996-05-10 1997-04-22 Agouti-related gene SI0917571T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1750596P 1996-05-10 1996-05-10
US08/757,541 US5766877A (en) 1996-05-10 1996-11-27 Genes encoding art, an agouti-related transcript
PCT/US1997/006853 WO1997043412A1 (en) 1996-05-10 1997-04-22 Novel agouti-related gene

Publications (1)

Publication Number Publication Date
SI0917571T1 true SI0917571T1 (en) 2005-06-30

Family

ID=26689965

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9730696T SI0917571T1 (en) 1996-05-10 1997-04-22 Agouti-related gene

Country Status (12)

Country Link
US (5) US5766877A (xx)
EP (1) EP0917571B1 (xx)
JP (1) JP4219404B2 (xx)
AT (1) ATE283917T1 (xx)
AU (1) AU2681497A (xx)
CA (1) CA2253238C (xx)
DE (1) DE69731834T2 (xx)
DK (1) DK0917571T3 (xx)
ES (1) ES2234015T3 (xx)
PT (1) PT917571E (xx)
SI (1) SI0917571T1 (xx)
WO (1) WO1997043412A1 (xx)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789651A (en) * 1993-05-21 1998-08-04 Martin Marietta Energy Systems, Inc. Isolation and characterization of Agouti: a diabetes/obesity related gene
US6310034B1 (en) 1993-05-21 2001-10-30 Ut-Battelle, Llc Agouti polypeptide compositions
WO2002064091A2 (en) * 2001-02-13 2002-08-22 Palatin Technologies, Inc. Melanocortin metallopeptides for treatment of sexual dysfunction
US5766877A (en) * 1996-05-10 1998-06-16 Amgen Inc. Genes encoding art, an agouti-related transcript
AU5243798A (en) * 1996-11-06 1998-05-29 Children's Medical Center Corporation Transgenic animal expressing a syndecan in the regions of hypothalamus
EP1040351B1 (en) * 1997-12-16 2007-07-18 Merck & Co., Inc. C-terminal region of agouti-related transcript (art) protein
US6878520B1 (en) * 1997-12-16 2005-04-12 Merck & Co., Inc. C-terminal region of agouti-related transcript (ART) protein
WO1999050295A2 (en) * 1998-03-30 1999-10-07 Gryphon Sciences Agouti-related protein analogs and methods of use
US6689873B1 (en) 1998-04-29 2004-02-10 Merck & Co., Inc. Nucleic acid encoding rat agouti related protein
WO2000014115A1 (en) * 1998-09-03 2000-03-16 Millennium Pharmaceuticals, Inc. Mc4-r as target for the identification of compounds used to treat drug addiction
US6716810B1 (en) * 1998-12-09 2004-04-06 Eleanor Roosevelt Institute Composition and method for regulation of body weight and associated conditions
US6603058B1 (en) 1998-12-09 2003-08-05 Oklahoma Medical Research Foundation Non-human animal model for obesity and uses thereof
US6303749B1 (en) 1999-01-29 2001-10-16 Amgen Inc. Agouti and agouti-related peptide analogs
US20030064921A1 (en) * 1999-10-27 2003-04-03 The Regents Of The University Of California Methods and compounds for modulating melanocortin receptor ligand binding and activity
EP1125579A3 (en) 2000-01-18 2003-01-02 Pfizer Products Inc. Uses of agrp-melanocortin receptor binding modulating compounds
AU7507001A (en) * 2000-05-31 2001-12-11 Du Pont Catalysts for olefin polymerization
EP1385823B1 (en) 2001-04-09 2006-12-13 Chiron Corporation Guanidino compounds as melanocortin-4 receptor (mc4-r) agonists
US20030207814A1 (en) * 2002-02-04 2003-11-06 Chiron Corporation Novel guanidinyl derivatives
US20030195187A1 (en) * 2002-02-04 2003-10-16 Chiron Corporation Guanidino compounds
US20050124652A1 (en) * 2002-02-04 2005-06-09 Rustum Boyce Guanidino compounds
WO2003072056A2 (en) * 2002-02-25 2003-09-04 Chiron Corporation Intranasal administration of mc4-r agonists
JP2005531583A (ja) 2002-05-23 2005-10-20 カイロン コーポレイション 置換キナゾリノン化合物
WO2004004447A2 (en) * 2002-07-03 2004-01-15 Merck & Co., Inc. Agouti-related protein deficient cells, non-human transgenic animals and methods of selecting compounds which regulate energy metabolism
JP2007501861A (ja) * 2003-05-23 2007-02-01 カイロン コーポレイション Ｍｃ４−ｒアゴニストとしてのグアニジノ置換キナゾリノン化合物
US20060173167A1 (en) * 2003-08-13 2006-08-03 Gunter Stempfer Process for the purification of recombinant polypeptides
MXPA06005736A (es) * 2003-11-19 2006-12-14 Chiron Corp Compuestos de quinazolinona con bioacumulacion reducida.
US6974187B2 (en) * 2004-01-28 2005-12-13 Tachi-S Co., Ltd. Vehicle seat structure
EP1753735A1 (en) * 2004-04-20 2007-02-21 Transtech Pharma, Inc. Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators
US7910101B2 (en) 2004-10-25 2011-03-22 Centocor, Inc. Melanocortin receptor binding mimetibodies, compositions, methods and uses
US20070021433A1 (en) 2005-06-03 2007-01-25 Jian-Qiang Fan Pharmacological chaperones for treating obesity
US7833927B2 (en) * 2005-08-31 2010-11-16 Rohm And Haas Company Single site palladium catalyst complexes
WO2010025142A1 (en) * 2008-08-29 2010-03-04 Transtech Pharma, Inc. Substituted aminothiazole derivatives, pharmaceutical compositions, and methods of use
CA2825098C (en) 2011-01-27 2020-03-10 Universite De Montreal Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4263428A (en) * 1978-03-24 1981-04-21 The Regents Of The University Of California Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
EP0052322B1 (de) * 1980-11-10 1985-03-27 Gersonde, Klaus, Prof. Dr. Verfahren zur Herstellung von Lipid-Vesikeln durch Ultraschallbehandlung, Anwendung des Verfahrens und Vorrichtung zur Durchführung des Verfahrens
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
DE3374837D1 (en) * 1982-02-17 1988-01-21 Ciba Geigy Ag Lipids in the aqueous phase
US4615885A (en) * 1983-11-01 1986-10-07 Terumo Kabushiki Kaisha Pharmaceutical composition containing urokinase
DE3572982D1 (en) * 1984-03-06 1989-10-19 Takeda Chemical Industries Ltd Chemically modified lymphokine and production thereof
EP0401384B1 (en) * 1988-12-22 1996-03-13 Kirin-Amgen, Inc. Chemically modified granulocyte colony stimulating factor
US5252714A (en) * 1990-11-28 1993-10-12 The University Of Alabama In Huntsville Preparation and use of polyethylene glycol propionaldehyde
US5766877A (en) * 1996-05-10 1998-06-16 Amgen Inc. Genes encoding art, an agouti-related transcript

Also Published As

Publication number Publication date
EP0917571A1 (en) 1999-05-26
CA2253238A1 (en) 1997-11-20
US7122520B2 (en) 2006-10-17
US5766877A (en) 1998-06-16
DE69731834D1 (de) 2005-01-05
ATE283917T1 (de) 2004-12-15
AU2681497A (en) 1997-12-05
PT917571E (pt) 2005-04-29
JP2001517931A (ja) 2001-10-09
US20010007752A1 (en) 2001-07-12
WO1997043412A1 (en) 1997-11-20
CA2253238C (en) 2008-08-12
DE69731834T2 (de) 2005-12-15
US6203995B1 (en) 2001-03-20
EP0917571B1 (en) 2004-12-01
ES2234015T3 (es) 2005-06-16
US20030082737A1 (en) 2003-05-01
JP4219404B2 (ja) 2009-02-04
DK0917571T3 (da) 2005-03-14
US6060589A (en) 2000-05-09

Similar Documents

Publication Publication Date Title
SI0917571T1 (en) Agouti-related gene
WO2001018172A3 (en) Fibroblast growth factor-like polypeptides
AU3246300A (en) Polypeptides having galactose oxidase activity and nucleic acids encoding same
WO2001072957A3 (en) Fibroblast growth factor-like molecules and uses thereof
WO2000018914A3 (en) Novel dkr polypeptides
WO1998021343A8 (en) Genes encoding telomerase proteins
NZ510356A (en) Molecules designated LDCAM
WO2001029222A3 (en) Polypeptides having phospholipase b activity and nucleic acids encoding same
HU9601448D0 (en) Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof
AU7381098A (en) Polypeptides having prolyl pipeptidyl aminopeptidase activity and nucleic acids encoding same
PT963377E (pt) Interleucina 19
MX9602977A (es) Proteinas que reparan la mala union de adn humano.
AU3802595A (en) Tripeptidyl aminopeptidase
AU7489098A (en) Polypeptides having aminopeptidase activity and nucleic acids encoding same
EP0920501B8 (en) Neuritin, a neurogene
CA2336261A1 (en) Cyclin e2 genes and proteins
WO2001077291A3 (en) Polynucleotides encoding novel secreted proteins
WO2001077289A3 (en) Polynucleotides encoding novel secreted proteins
WO1995030001A3 (en) Novel p-selectin ligand protein
WO2001077288A3 (en) Polynucleotides encoding novel secreted proteins
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
AU5727099A (en) A 2,6-beta-d-fructan hydrolase enzyme and processes for using the enzyme
WO2000020450A3 (en) Calcium channel alpha-2/delta gene
EP0801133A3 (en) Hydroperoxide lyases
WO2000041509A3 (en) Polypeptides having acid phosphatase activity and nucleic acids encoding same